Transarterial Chemoembolization: Clinical Trials

2 trials for Transarterial Chemoembolization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow Transarterial Chemoembolization: new trials by email Literature Review of Transarterial Chemoembolization trials Research Report on Transarterial Chemoembolization

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma
DEB-TACE combined with apatinib and PD-1 antibody - Intrahepatic Cholangiocarcinoma, Transarterial Chemoembolization
Phase 2CompletedSichuan Cancer Hospital and Research Institute202024-07-012026-04-07
The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma
lenvatinib + sindilimab/carrelizumab, TACE - Hepatocellular Carcinoma Non-resectable, Transarterial Chemoembolization
Phase 1 / Phase 2CompletedXinrui Zhu,MD1422020-10-012025-08-29

Narrower conditions

Cholangiocarcinoma (1)

Broader conditions

Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

apatinib (1)  ·  camrelizumab (1)  ·  lenvatinib (1)

Sponsors

Sichuan Cancer Hospital and Research Institute (1)  ·  Xinrui Zhu,MD (1)

Countries

China (2)